Pharmaceutical

Eli Lilly’s retatrutide sets new record for weight loss in obesity space

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

Jul 3, 2023 - 20:00
Eli Lilly’s retatrutide sets new record for weight loss in obesity space
Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.
Read the original article

Tags:

Previous Article

Cyltezo Pen: first interchangeable biosimilar to Humira rolls out across US

Next Article

Chinese NMPA approves Innovent and IASO Bio’s myeloma therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: How the twin crises of climate change and poor public housing are harming people’s health

Opinion: How the twin crises of climate change and poor...

Aug 29, 2023

Panbela obtains rights to develop and commercialise Flynpovi to treat FAP

Panbela obtains rights to develop and commercialise Fly...

Apr 12, 2023

MHRA revokes Novartis’ Adakveo authorisation for sickle cell disease

MHRA revokes Novartis’ Adakveo authorisation for sickle...

Feb 22, 2024